Cullinan Therapeutics CGEM
NASDAQ CGEM
$15.19 -0.04 (-0.26%)
As of: Sep 30, 2026 · 10:09 AM EDT

Cullinan Therapeutics (CGEM) Accounts Payables (2020 - 2026)

Updated

Cullinan Therapeutics' Accounts Payables was $3.73 million in Q2 2026, up 51.4% from $2.46 million a year earlier and up 48.5% from the prior quarter.

Analysis

Cullinan Therapeutics (CGEM) Accounts Payables (2020 - 2026) Analysis & Trends

At the end of FY2025, Accounts Payables at Cullinan Therapeutics came in at $841,000, down 50.0% from FY2024.

  • Accounts Payables has now declined for five consecutive years, with a five-year compound annual growth rate of -38.7% (FY2020 to FY2025).
  • In earlier years, Accounts Payables was $1.68 million in FY2024 (-32.5%), $2.49 million in FY2023 (-6.3%), $2.66 million in FY2022 (-16.1%) and $3.17 million in FY2021 (-67.3%).
  • The Q2 2026 figure marks the highest quarterly Accounts Payables since Q1 2022.
  • Compared with a year earlier, Accounts Payables was higher in two of the last eight quarters, with an average decline of 4.7%.
  • The best year-over-year quarter for Accounts Payables over five years was Q2 2022 (growth of 105.2%); the worst was Q1 2023 (a decline of 67.8%).
  • Per Business Quant data, CGEM's Accounts Payables in the three quarters before Q2 2026 was $2.51 million (Q1 2026), $841,000 (Q4 2025) and $1.72 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 9.22 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.30 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -22.89 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 674.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 429.50 Mn
10 Cullinan Therapeutics 961.97 Mn 961.97 Mn - 3.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.73 Mn
Mar 31, 2026 2.51 Mn
Dec 31, 2025 841,000.00
Sep 30, 2025 1.72 Mn
Jun 30, 2025 2.46 Mn
Mar 31, 2025 3.40 Mn
Dec 31, 2024 1.68 Mn
Sep 30, 2024 2.12 Mn
Jun 30, 2024 1.56 Mn
Mar 31, 2024 3.71 Mn
Dec 31, 2023 2.49 Mn
Sep 30, 2023 2.40 Mn
Jun 30, 2023 2.49 Mn
Mar 31, 2023 2.03 Mn
Dec 31, 2022 2.66 Mn
Sep 30, 2022 2.40 Mn
Jun 30, 2022 3.10 Mn
Mar 31, 2022 6.31 Mn
Dec 31, 2021 3.17 Mn
Sep 30, 2021 2.02 Mn
API Access

Cullinan Therapeutics Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=CGEM&period=max&api_key=YOUR_API_KEY